Abstract
A rational approach to hypopigmented disorders needs a clear and widely accepted classification and meta-analysis of the literature to position the medical, physical, surgical, and combined treatments available in terms of safety and effectiveness profiles. Best available scientific evidence must be rationally adapted to the patient's expectations and to the clinical presentation of the hypopigmentary disease, to reach the most valid final results.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Antioxidants / therapeutic use
-
Cosmetics / therapeutic use
-
Dermatologic Agents / administration & dosage
-
Dermatologic Agents / adverse effects
-
Dermatologic Agents / therapeutic use*
-
Humans
-
Hypopigmentation / diagnosis
-
Hypopigmentation / drug therapy*
-
Hypopigmentation / therapy
-
Laser Therapy
-
PUVA Therapy / methods
-
Phototherapy / methods
-
Sunscreening Agents / therapeutic use
-
Ultraviolet Therapy / methods
-
Vitamins / therapeutic use
-
Vitiligo / diagnosis
-
Vitiligo / drug therapy*
-
Vitiligo / therapy
Substances
-
Adrenal Cortex Hormones
-
Antioxidants
-
Cosmetics
-
Dermatologic Agents
-
Sunscreening Agents
-
Vitamins